- Trials with a EudraCT protocol (155)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
155 result(s) found for: Bronchodilators.
Displaying page 1 of 8.
EudraCT Number: 2013-003127-11 | Sponsor Protocol Number: CQVA149A3401 | Start Date*: 2014-02-26 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A prospective, multicenter, 12-week, randomized open-label study to evaluate the efficacy and safety of glycopyrronium (50 micrograms o.d.) or indacaterol maleate and glycopyrronium bromide fixed-d... | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) LT (Completed) SK (Completed) BE (Completed) EE (Completed) LV (Completed) IE (Completed) SE (Completed) AT (Completed) PT (Completed) IT (Completed) GB (Completed) DK (Completed) GR (Completed) HU (Completed) PL (Completed) ES (Completed) DE (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000725-18 | Sponsor Protocol Number: MAB110123 | Start Date*: 2008-04-03 |
Sponsor Name:GlaxoSmithKline Reaseach & Development | ||
Full Title: A randomised, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbut... | ||
Medical condition: Chronic Obstructive Pulmonary Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000313-33 | Sponsor Protocol Number: NL72651 | Start Date*: 2020-07-08 |
Sponsor Name:UMC Utrecht | ||
Full Title: ‘Bronchodilators for wheeze in young children presenting to primary care: a randomised, placebo-controlled, multicentre, parallel group trial’ | ||
Medical condition: Wheezing in infants and young children (6-24 months old) | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) BE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000473-12 | Sponsor Protocol Number: ULT01 | Start Date*: 2015-10-12 |
Sponsor Name:UMCG | ||
Full Title: The effectiveness of single dose Ultibro Breezhaler (indacaterol/glycopyrronium) by sd-DPI versus ipratropium/salbutamol by nebulizer in improving FEV1 and dyspnea during stable state of COPD | ||
Medical condition: COPD, chronic obstructive pulmonary disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-002590-10 | Sponsor Protocol Number: P130906 | Start Date*: 2016-02-11 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Effect of bronchodilators on effort induced dyspnoea in patients suffering lung hypertension | |||||||||||||
Medical condition: Idiopathic or heritable patients with pulmonary arterial hypertension (PAH). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001005-16 | Sponsor Protocol Number: CQAB149B2338 | Start Date*: 2007-07-12 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 26 week treatment, randomized, multi center, double blind, double dummy, parallel-group study to assess the safety of indacaterol (300 and 600 µg o.d.) in patients with moderate to severe persist... | |||||||||||||
Medical condition: moderate and severe persisitent asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) DE (Completed) FR (Completed) IT (Completed) SK (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005557-30 | Sponsor Protocol Number: FB/PS/14/165/06 | Start Date*: 2007-03-16 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster®, Chiesi) in healthy volunteers, asthmatic... | |||||||||||||
Medical condition: The study is focused on asthma bronchiale and chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019047-19 | Sponsor Protocol Number: 03-2010 | Start Date*: 2010-05-10 |
Sponsor Name:Pneumologia c/o Villa Pineta | ||
Full Title: ADDITIONAL EFFECT OF TIOTROPIUM BROMIDE ON EXERCISE TOLERANCE IN COPD PATIENTS. PILOT STUDY | ||
Medical condition: COPD (Chronic Obstructive Pulmonary Disease) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001429-34 | Sponsor Protocol Number: TRITEX_COPD | Start Date*: 2021-10-05 | |||||||||||
Sponsor Name:University Hospital Mutua de Terrassa | |||||||||||||
Full Title: Utility of inhaled extrafine triple therapy with glycopyrronium bromide, formoterol fumarate dihydrate and beclometasone dipropionate to improve expiratory flow limitation in severe COPD exacerbati... | |||||||||||||
Medical condition: Severe exacerbation of chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002536-41 | Sponsor Protocol Number: RPL554-009-2015 | Start Date*: 2015-09-18 | |||||||||||
Sponsor Name:Verona Pharma plc | |||||||||||||
Full Title: A phase II, randomised, double blind, placebo controlled, six way crossover study to assess the bronchodilator effect of RPL554 administered on top of salbutamol and ipratropium in patients with COPD | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002899-25 | Sponsor Protocol Number: CQVM149B2302 | Start Date*: 2015-12-17 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, randomized, 52-week, double-blind, parallel-group, active-controlled study to compare the efficacy and safety of QVM149 with QMF149 in patients with asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) LT (Completed) DE (Completed) SK (Completed) PT (Completed) AT (Completed) HU (Completed) NL (Completed) FI (Completed) BE (Completed) ES (Completed) DK (Completed) LV (Completed) GR (Completed) FR (Completed) BG (Completed) IE (Completed) HR (Completed) SI (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003344-62 | Sponsor Protocol Number: mitHDAC | Start Date*: 2005-11-15 |
Sponsor Name:Imperial College | ||
Full Title: Effect of theophylline on histone deacetylase activity: enhancement of in-vitro glucocorticoid function in patients with COPD. | ||
Medical condition: Chronic Obstructive Lung Disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005874-65 | Sponsor Protocol Number: ISS-UZA-5/26/99 | Start Date*: 2006-01-13 |
Sponsor Name:University Hospital Antwerp | ||
Full Title: Non-invasive monitoring of airway inflammation in asthmatic patients during adaptation of inhaled steroid therapy | ||
Medical condition: asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002553-35 | Sponsor Protocol Number: CQAW039A2307 | Start Date*: 2016-02-20 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 52-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe ast... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) AT (Completed) DE (Completed) EE (Completed) LV (Completed) BE (Completed) IS (Completed) FI (Completed) DK (Completed) FR (Completed) PL (Completed) LT (Completed) IE (Prematurely Ended) ES (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001123-11 | Sponsor Protocol Number: FFA100240 | Start Date*: 2006-03-15 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder 25mcg, 50mcg, 100mcg, and 200mcg Administered Onc... | ||
Medical condition: Persistent asthma | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) EE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-006096-37 | Sponsor Protocol Number: BAY 12-8039/11980 | Start Date*: 2008-05-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG, Leverkusen, Germany | |||||||||||||
Full Title: A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the ... | |||||||||||||
Medical condition: acute exacerbation of chronic bronchitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (Completed) IE (Completed) BE (Completed) DE (Completed) ES (Completed) PT (Completed) GR (Completed) LT (Completed) LV (Completed) IT (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002529-21 | Sponsor Protocol Number: CQVM149B2301 | Start Date*: 2015-10-25 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter randomized 52 week treatment double-blind, triple dummy parallel group study to assess the efficacy and safety of QMF149 compared to mometasone furoate in patients with asthma | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) EE (Completed) LV (Completed) DE (Completed) LT (Completed) HU (Completed) CZ (Completed) SK (Completed) IE (Completed) PL (Completed) BG (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002340-40 | Sponsor Protocol Number: A9111004 | Start Date*: 2014-10-16 | |||||||||||
Sponsor Name:Pfizer Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled 2-Way Crossover Study to Evaluate the Efficacy, Safety and Tolerability of PF-03715455 Administered Twice Daily By Inhalation for 4 Weeks in Subjects ... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000221-39 | Sponsor Protocol Number: M15-539 | Start Date*: 2017-12-14 |
Sponsor Name:AbbVie Inc | ||
Full Title: A Prospective, International, Multicenter, Open-Label, Non-Controlled Study of Safety and Effectiveness of Palivizumab, in Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infectio... | ||
Medical condition: Severe Respiratory Syncytial Virus (RSV) Infection | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2006-003561-13 | Sponsor Protocol Number: cro488 | Start Date*: 2006-12-04 |
Sponsor Name:imperial college | ||
Full Title: Reversal of steroid insensitivity in COPD by theophylline | ||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
